Joensuu Biomass And Hamina Biorefinery Will Evolve Amid Risks

Published
11 Feb 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
€9.10
23.1% undervalued intrinsic discount
08 Aug
€7.00
Loading
1Y
-18.5%
7D
-0.7%

Author's Valuation

€9.1

23.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 7.44%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 12%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on13 Mar 25
Fair value Increased 6.89%

AnalystConsensusTarget has decreased revenue growth from 0.7% to -4.9% and increased future PE multiple from 14.6x to 18.0x.